Raymond James analyst Andrew Marok upgraded Integral Ad Science Holding Corp. to Strong Buy from Outperform with a price target of $27, up from $26. The price target implies an upside of 69 percent.
Marok had a strong conviction level in Integral Ad Science’s long-term fundamental prospects combined with the stock’s recent selloff, which he termed “unjustified.”
Recently, Integral Ad Science reported fourth-quarter FY21 revenue growth of 31 percent year-on-year to $102.47 million, beating the consensus of $94.83 million.
Integral Ad Science sees Q1 revenue of $85 million–$87 million above the consensus of $84.41 million. It expects FY22 revenue of $416 million–$424 million above the consensus of $404.37 million.
Recently, Barclays saw Meta Platforms Inc.’s opening up of feed for Brand Suitability as a positive for Integral Ad Science.
